In focus · trending topic

VEGF

3 stories · following the connections

OncoMed Initiates Enrollment of Phase 1b Clinical Trial of Anti-DLL4/VEGF Bispecific Antibody as Second-line Treatment for Metastatic Colorectal Cancer Patients

By Nasdaq OMXJan 4, 2017, 1:32 PM UTC

OncoMed Initiates Enrollment of Phase 1b Clinical Trial of Anti-DLL4/VEGF Bispecific Antibody as Second-line Treatment for Metastatic Colorectal Cancer Patients

By Nasdaq OMXJan 4, 2017, 1:32 PM UTC

OncoMed Initiates Enrollment of Phase 1b Clinical Trial of Anti-DLL4/VEGF Bispecific Antibody as Second-line Treatment for Metastatic Colorectal Cancer Patients

By Nasdaq OMXJan 4, 2017, 1:32 PM UTC